How do I get GLP-1 medications in Chicago?

Chicago residents can get GLP-1 medications through licensed telehealth providers that ship compounded semaglutide or tirzepatide directly to Illinois addresses, or by seeing a local clinician in person and filling a brand-name prescription (Wegovy, Zepbound, Ozempic, Mounjaro) at a retail pharmacy. Telehealth providers that serve Illinois are listed above.

Is telehealth GLP-1 legal in Chicago?

Yes — telehealth prescribing of GLP-1 medications is legal in Illinois. Licensed providers can conduct an online evaluation, prescribe semaglutide or tirzepatide when clinically appropriate, and arrange delivery to your address through a partner pharmacy.

How much does compounded semaglutide cost in Chicago?

Compounded semaglutide pricing is set at the provider level, not the city level, and varies by dose and plan. See the pricing columns on each provider card above for the current monthly cost from providers that serve Illinois. Brand-name Wegovy and Zepbound retail list prices are $1,000-$1,350 per month without insurance.

Does insurance cover GLP-1s in Chicago?

Insurance coverage in Chicago follows Illinois plan-level rules. Most commercial plans cover Ozempic and Mounjaro for type 2 diabetes diagnoses, but coverage for Wegovy and Zepbound (the obesity-indicated versions) is much more limited and typically requires prior authorization. Check your plan's formulary for the specific drug and indication you need.

What's the cheapest way to get GLP-1s in Chicago?

The lowest-cost route for Chicago residents is usually compounded semaglutide or tirzepatide through telehealth, averaging around $209/month in Illinois — well below brand-name Wegovy ($1,349/mo) or Zepbound ($1,086/mo) without insurance. Compare current pricing from providers serving Chicago above, or check if your insurance covers a brand-name option first.

Does Illinois Medicaid cover weight-loss GLP-1s?

Illinois Medicaid coverage for GLP-1 weight-loss medication is currently: Diabetes + obesity (with prior auth). Ozempic and Mounjaro are generally covered for type 2 diabetes, while the obesity-indicated versions (Wegovy, Zepbound) typically require prior authorization or aren't covered at all, depending on the plan.

How many GLP-1 providers serve Chicago?

176 GLP-1 telehealth and in-person providers currently serve Chicago residents, based on our tracked pricing and availability data. See the full ranked list above, or browse the A-Z index for every provider that ships to Illinois.

GLP-1 Weight Loss in Chicago (2026)

176 GLP-1 telehealth providers ship to Chicago, Illinois. Compounded semaglutide averages $209/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Featured Partners · Chicago

Featured GLP-1 providers serving Chicago

No insurance needed
reader-supported

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Top pick
7.6
Maximus
Compounded from
$249.99/mo
Save $1,099.01/mo vs Wegovy
Get started →
8.3
Found
Compounded from
$99/mo
Save $1,250/mo vs Wegovy
Get started →
7.4
Breeze Meds
Compounded from
$199/mo
Save $1,150/mo vs Wegovy
Get started →
6.2
Wellorithm
Compounded from
$147/mo
Save $1,202/mo vs Wegovy
Get started →
8.2
Gala
Compounded from
$149/mo
Save $937/mo vs Zepbound
Get started →
6.9
TMates
Compounded from
$249/mo
Save $1,100/mo vs Wegovy
Get started →

Provider	Compounded from	Save vs brand
7.6MaximusTop pick	$249.99/mo	Save $1,099.01/mo	Get started →
8.3Found	$99/mo	Save $1,250/mo	Get started →
7.4Breeze Meds	$199/mo	Save $1,150/mo	Get started →
6.2Wellorithm	$147/mo	Save $1,202/mo	Get started →
8.2Gala	$149/mo	Save $937/mo	Get started →
6.9TMates	$249/mo	Save $1,100/mo	Get started →

See all 176 GLP-1 providers serving Chicago ↓

Chicago at a Glance

Chicago population

2,693,976

City proper

Metro-area population

9,500,000

Wider telehealth market

Illinois obesity rank

#26 of 50

1 = highest prevalence

Illinois avg. compounded price

$209/mo

Semaglutide, cash-pay

About GLP-1 Access in Chicago

Chicago is third-largest city in the United States, located in Illinois with a population of approximately 2.7 million. Telehealth is legal in Illinois, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Chicago ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The greater Chicago metro area is home to roughly 9,500,000 residents — one of the larger telehealth markets in Illinois, even though the city proper is smaller.

Illinois's adult obesity rate is approximately 31.4% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Illinois ranks #26 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Chicago residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Illinois Medicaid covers GLP-1s for obesity with prior authorization, so Chicago residents on Medicaid should start by asking their prescriber to document a qualifying BMI and comorbidities for the PA request.

Looking beyond Chicago? See all GLP-1 providers in Illinois, or read our Illinois Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Semaglutide in Chicago

Best providers, pricing, and how to get started.

Tirzepatide in Chicago

Best providers, pricing, and how to get started.

All GLP-1 Providers Serving Chicago

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%

8.5

Effectiveness25%

8.5

User Experience15%

8.5

Trust & Safety15%

7.8

Accessibility10%

Support10%

8.4

Pros

✓LegitScript certified — rigorous pharmacy standards
✓Free 2-day shipping nationwide
✓Both semaglutide and tirzepatide available
✓Lowest per-month pricing in the compounded segment
✓24/7 support team
✓All 50 states covered

Cons

✗Compounded only — no brand-name Ozempic or Wegovy
✗Newer brand with fewer independent reviews than legacy players

Starting from $99/moRead full review →

Visit CoreAge Rx →

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

8.5

Trust & Safety15%

Accessibility10%

8.5

Support10%

8.9

Pros

✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
✓Unlimited clinician messaging and dose-adjustment support included

Cons

✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
✗No insurance accepted — cash pay, HSA/FSA eligible
✗Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month

Starting from $112/moRead full review →

Visit Enhance MD →

bmiMD

Verified partner

Best for: mainstream telehealth GLP-1 access

8.1

Medical weight loss clinic offering GLP-1 prescriptions through telehealth.

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

7.5

Trust & Safety15%

7.3

Accessibility10%

8.5

Support10%

Pros

✓Both semaglutide and tirzepatide available

Cons

✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection

Starting from $99/moRead full review →

Visit bmiMD →

Pallas Health

Verified partner

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

8.1

Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro. Compounded plans average $199 and $299 a month with provider care, check-ins and messaging included and no separate membership fee, and the price stays the same at every dose. Its clinical disclosures page is unusually complete: two named advising physicians with verifiable NPIs, the clinical partner Lion MD, six named partner pharmacies, and coverage in all 50 states plus DC.

Score Breakdown

Value25%

7.5

Effectiveness25%

User Experience15%

8.5

Trust & Safety15%

Accessibility10%

Support10%

Pros

✓Names six partner pharmacies with phone numbers and websites, the most complete pharmacy disclosure we have recorded.
✓Publishes two advising physicians with NPI numbers you can verify yourself in the federal NPPES registry.
✓Price stays the same at every dose, and provider care, check-ins and messaging are included with no membership fee.
✓Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro alongside compounded options, and serves all 50 states plus DC.

Cons

✗Billed $597 every 12 weeks, not monthly; at 4.33 cycles a year the true cost is about $216/mo, above the $199 advertised.
✗The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
✗Canceling after a payment deducts third-party processing costs plus a $5 fee per refunded payment.
✗In states requiring a live video visit a $60 deposit is taken at checkout, and it may be retained if you abandon the intake.

Starting from $139/moRead full review →

Visit Pallas Health →

RxSpan MD

Verified partner

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.1

RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, offering compounded GLP-1 weight loss — semaglutide and tirzepatide from $249/mo, as injections or oral capsules — plus brand-name Wegovy, Zepbound and Ozempic. It's unusually transparent: it names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group, ships free, and includes unlimited 24/7 support. Available in all 50 states.

Score Breakdown

Value25%

Effectiveness25%

8.5

User Experience15%

7.5

Trust & Safety15%

9.3

Accessibility10%

8.5

Support10%

8.9

Pros

✓Physician-led — founded by Dr. John Diaz, a board-certified plastic surgeon with 20+ years' experience
✓Compounded semaglutide and tirzepatide from $249/mo (injection or oral capsules), plus brand-name Wegovy, Zepbound and Ozempic
✓Names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group
✓LegitScript-certified (#50405601); free expedited shipping and unlimited 24/7 support included
✓Available in all 50 states via a 2-minute assessment

Cons

✗Compounded pricing ($249 semaglutide / $329 tirzepatide) sits mid-to-high versus the cheapest telehealth options
✗Brand-name GLP-1 is priced steeply (Wegovy $1,349, Ozempic $1,299, Zepbound $1,069)
✗Multi-vertical practice (also hair, sexual health, longevity), not weight-loss-only
✗Legal entity name isn't published on the site

Editorial score · methodology

$88/mosemaglutide

$157/motirzepatide

CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified

Get Started Read full Sunlight review →

Browse all 302 providers with undisclosed Chicago coverage A–Z

In-Person vs Telehealth in Chicago

Patients in Chicago have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Illinois addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Illinois varies by plan^[4].

Cost of GLP-1 Medications in Chicago

Average compounded semaglutide (Illinois)^[1]

$209/month

Brand-name Wegovy in Chicago typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $209/month in Illinois, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Semaglutide · Drugs and brands
Tirzepatide · Drugs and brands
Compounded GLP-1 · Pharmacy and drug forms
503A pharmacy · Pharmacy and drug forms
PCAB accreditation · Pharmacy and drug forms
Prior authorization (PA) · Insurance and regulatory
Off-label use · Insurance and regulatory
FDA Drug Shortage List · Insurance and regulatory

Compare All Providers Calculate Savings

Get Chicago Price Alerts

Be the first to know about new GLP-1 providers and price changes in Chicago.

Sources & methodology — as of August 2026

1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.